Gene · 3753
Papers2,266
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,266
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long QT syndrome-associated calmodulin variants disrupt the activity of the slowly activating delayed rectifier potassium channel. | J Physiol | 2023 | 37428651 | PubTator, text mining | PubMed |
| Psychological stress, the central nervous system and arrhythmias. | QJM | 2023 | 37405867 | PubTator, text mining | PubMed |
| Mechanisms of fever-induced QT prolongation and torsades de pointes in patients with KCNH2 mutation. | Europace | 2023 | 37386841 | PubTator, text mining | PubMed |
| Subtype-specific modulation of human KV 7 channels by the anticonvulsant cannabidiol through a lipid-exposed pore-domain site. | Br J Pharmacol | 2023 | 37377025 | PubTator, text mining | PubMed |
| Mechanisms of Atrial Fibrillation: How Our Knowledge Affects Clinical Practice. | Life (Basel) | 2023 | 37374043 | PubTator, text mining | PubMed |
| Mechanistic insights into robust cardiac IKs potassium channel activation by aromatic polyunsaturated fatty acid analogues. | Elife | 2023 | 37350568 | PubTator, text mining | PubMed |
| The Phosphorylation of Kv1.3: A Modulatory Mechanism for a Multifunctional Ion Channel. | Cancers (Basel) | 2023 | 37345053 | PubTator, text mining | PubMed |
| Identification of a novel pathogenic variant in KCNH2 in an Iranian family with long QT syndrome 2 by whole-exome sequencing. | J Arrhythm | 2023 | 37324772 | PubTator, text mining | PubMed |
| Ancient medicinal plant rosemary contains a highly efficacious and isoform-selective KCNQ potassium channel opener. | Commun Biol | 2023 | 37322081 | PubTator, text mining | PubMed |
| Cycling matters: Sex hormone regulation of vascular potassium channels. | Channels (Austin) | 2023 | 37243715 | PubTator, text mining | PubMed |
| Slowly activating voltage-gated potassium current potentiation by ML277 is a novel cardioprotective intervention. | PNAS Nexus | 2023 | 37234204 | PubTator, text mining | PubMed |
| Novel SCN5A frame‑shift mutation underlying in patient with idiopathic ventricular fibrillation manifested with J wave in inferior lead and prolonged S‑wave in precordial lead. | Exp Ther Med | 2023 | 37206574 | PubTator, text mining | PubMed |
| IKs Activator ML277 Mildly Affects Repolarization and Arrhythmic Outcome in the CAVB Dog Model. | Biomedicines | 2023 | 37189765 | PubTator, text mining | PubMed |
| Does Enhanced Structural Maturity of hiPSC-Cardiomyocytes Better for the Detection of Drug-Induced Cardiotoxicity? | Biomolecules | 2023 | 37189424 | PubTator, text mining | PubMed |
| Post-mortem genetic testing in sudden cardiac death and genetic screening of relatives at risk: lessons learned from a Czech pilot multidisciplinary study. | Int J Legal Med | 2023 | 37178278 | PubTator, text mining | PubMed |
| Human leukocyte antigen F-associated transcript 10 regulates the IKs potassium channel by competing for Kv7.1 ubiquitination. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37122222 | PubTator, text mining | PubMed |
| Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome. | Philos Trans R Soc Lond B Biol Sci | 2023 | 37122211 | PubTator, text mining | PubMed |
| Human Sinoatrial Node Pacemaker Activity: Role of the Slow Component of the Delayed Rectifier K+ Current, IKs. | Int J Mol Sci | 2023 | 37108427 | PubTator, text mining | PubMed |
| Revisiting Genetic Epidemiology with a Refined Targeted Gene Panel for Hereditary Hearing Impairment in the Taiwanese Population. | Genes (Basel) | 2023 | 37107638 | PubTator, text mining | PubMed |
| Targeting Small-Conductance Calcium-Activated Potassium Channels in Atrial Fibrillation: Therapeutic Opportunities. | Circ Res | 2023 | 37104564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3753/papers?page=8